Short Summary
The PTAB denied the IPR petition, finding that the preliminary record did not present a compelling challenge to the patent's validity despite multiple grounds of obviousness. The Board relied on a holistic review of the Fintiv factors, ultimately favoring discretionary denial under 35 U.S.C. § 314(a).
Detailed Summary
The Patent Trial and Appeal Board denied the IPR petition concerning wireless communication technology (CORESET configuration), finding that the preliminary record failed to present a compelling challenge to the patent's validity. The decision was based on a holistic balancing of the Fintiv factors, which favored discretionary denial under 35 U.S.C. § 314(a). While the Board acknowledged arguments regarding specific limitations in prior art (Nogami/Chatterjee) and parallel district court litigation, it concluded that Petitioner's arguments were insufficient to overcome the presumption of validity.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in AT&T Services Inc. et al. vs ASUS Technology Licensing Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsClear Imaging Research LLC
Google petitions the PTAB to invalidate Clear Imaging’s 32‑claim video‑stabilization patent, alleging obviousness over four prior‑art references and arguing claim‑term constructions. The petition seeks cancellation of all claims.
Meta Platforms, Inc.vsSitnet, LLC
The PTAB issued a Final Written Decision finding that the patent claims were unpatentable by a preponderance of the evidence. The Board found obviousness over single and combined prior art references (Gage/Mitchell) for original claims, and also determined substitute claims failed both 103 and 101 standards.
Olympus Corporation et al.vsOptimum Imaging Technologies LLC
Olympus and other camera makers settled with Optimum Imaging Technologies, leading to the termination of four inter partes review proceedings covering patent 10,873,685. The Board granted the joint motion to terminate and ordered the settlement agreement to be kept confidential.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck challenges Halozyme’s request for Director review after the PTAB instituted a post‑grant review of U.S. Patent 12,018,298 covering modified PH20 polypeptides. Merck argues the eligibility and claim‑construction issues are meritless and that the Fintiv factors favor institution.
Normshield, Inc. d/b/a Black Kite Inc.vsBitSight Technologies, Inc.
Normshield and BitSight reached a confidential settlement that led the PTAB to terminate IPR2025-00276 before any institution decision. The Board granted the joint motion to terminate and ordered the settlement agreement kept confidential.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.